2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

講師

Rong Jin Lin

Session 4 – Cross Border Investments
Date: 25 July (Thursday)  14:00 – 17:40
Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom A
 


 

Rong jin Lin

Chairman
Center Laboratories Inc.

 
Expertise
  • Biotechnology entrepreneurship and investment
  • Enterprise positioning and restructuring
  • Business strategy & organizational model
  • International resource integration
Professional Experience
  • Chairman and General Manager, TTY Biopharm Company Limited
  • Chairman, PharmaEngine, Inc.
Education
  • Honorary Doctorate, College of Medicine, Taipei Medical University
  • B.S., College of Pharmacy, Taipei Medical University

Session Speech Title & Synopsis:
The Key Drivers and Success Story for M&A in Biotechnology Sectoor
 
The growth of a company included the organic and strategic growth; and the strategic growth usually can be achieved by diverse approaches like partnerships, alliances, mergers, acquisitions, joint ventures, buy-outs and spin-outs. In pharmseutical industry, new drug development is a challenging and lengthy process, most of the companies have difficulties to survive from this costly and time-consuming journey. How to flexibly use the above approaches to overcome the hurdles will be the key to determining the sustain of a company. Mr. Rongjin Lin will be sharing his over thirty years’ experience in several case studies in the following session.